Stocks · News reference
This Chewy Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Analysts downgraded Chewy, Cooper Companies, AngloGold Ashanti and Crescent Capital BDC, cutting ratings and/or price targets.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
BMO Capital Downgrades Anglogold Ashanti to Market Perform, Maintains Price Target to $115
BMO Capital analyst Raj Ray downgrades Anglogold Ashanti (NYSE:AU) from Outperform to Market Perform and maintains the price target from $115 to $115.
SSRM Advances With Marigold Growth Initiatives: Can They Aid Upside?
SSR Mining Inc. (SSRM) is advancing growth initiatives at its Marigold mine in Nevada, including the Buffalo Valley project, with an updated life-of-mine plan expected by end of 2026. The company expects 2026 Marigold production of 170,000-200,000 ounces, heavily weighted to Q4 with higher grades driving output. SSRM increased 2026 growth capital guidance from $48M to $65M and continues exploration at brownfield targets. The stock trades at a forward P/E of 9.55x, below industry average, with 2026 earnings consensus of $3.87/share (+92.5% YoY), though recent estimates have declined.
B of A Securities Downgrades Crescent Capital BDC to Neutral, Lowers Price Target to $10.25
B of A Securities analyst Derek Hewett downgrades Crescent Capital BDC (NASDAQ:CCAP) from Buy to Neutral and lowers the price target from $13 to $10.25.
These Analysts Revise Their Forecasts On Chewy Following Q2 Results
Chewy’s Q2 sales missed estimates while EPS matched; it raised FY2026 revenue and margin forecasts, though shares fell and analysts cut targets.
Rosenblatt Maintains Neutral on Chewy, Lowers Price Target to $24
Rosenblatt analyst Scott Devitt maintains Chewy (NYSE:CHWY) with a Neutral and lowers the price target from $25 to $24.